Ireland
--:--IST
Latest
Clinical Trials in Italy / NCT06797908
Recruiting Observational

Systemic Arterial Hypertension in Pediatric Age.

NCT06797908 · tracked via the Priya Life Science Italy tracker
Phase
Observational
Started
2020-10-13
Last updated
2025-01-29

Condition(s) studied

Hypertension

Study summary

We decided to conduct this study because hypertension in childhood increases the risk of developing cardiovascular disease (such as heart attack or stroke) in adulthood, beginning to damage important structures and organs, such as blood vessels, heart, and kidneys, from an early age. There is a clear need to identify those at greatest risk of developing hypertension as early as possible and to follow them appropriately.

The main objectives of the study are to describe the causes of hypertension, study the clinical-laboratory features in the patient with hypertension (such as associated symptoms or conditions, or altered blood test values), evaluate the possible involvement of the heart, and describe the overall approach to the patient with hypertension, from diagnosis (i.e., identification of the condition) to treatment.

Eligibility

Sex
ALL
Min age
—
Max age
18 Years
Healthy volunteers
No
Inclusion Criteria: * Patients younger than 18 years of age with hypertension and normal-high blood pressure Exclusion Criteria: * Patients with normal blood pressure values

Primary outcome measure(s)

Trial sites (3)

FacilityCityRegionStatus
IRCCS Azienda Ospedaliero - Universitaria di Bologna, U.O. Cardiologia Pediatrica e dell'età evolutiva Bologna Bologna Recruiting
IRCCS Azienda Ospedaliero - Universitaria di Bologna, U.O. Pediatria d'Urgenza, Pronto Soccorso e Osservazione Breve ed Intensiva Bologna Bologna Recruiting
IRCCS Azienda Ospedaliero - Universitaria di Bologna, U.O. Pediatria Bologna Bologna Recruiting

More IRCCS Azienda Ospedaliero-Universitaria di Bologna trials in Italy

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06797908 on ClinicalTrials.gov ↗ ← All trials in Italy